Negative/JJ
regulation/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
expression/NN
in/IN
monocytes/NNS
:/:
role/NN
of/IN
the/DT
65-kDa/JJ
plus/CC
50-kDa/JJ
NF-kappa/NN
B/NN
dimer/NN
./.

Although/IN
monocytic/JJ
cells/NNS
can/MD
provide/VB
a/DT
reservoir/NN
for/IN
viral/JJ
production/NN
in/FW
vivo/FW
,/,
their/PRP$
regulation/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
(/(
HIV-1/NN
)/)
transcription/NN
can/MD
be/VB
either/CC
latent/JJ
,/,
restricted/JJ
,/,
or/CC
productive/JJ
./.
=====
These/DT
differences/NNS
in/IN
gene/NN
expression/NN
have/VBP
not/RB
been/VBN
molecularly/RB
defined/VBN
./.
=====
In/IN
THP-1/NN
cells/NNS
with/IN
restricted/JJ
HIV/NN
expression/NN
,/,
there/EX
is/VBZ
an/DT
absence/NN
of/IN
DNA-protein/JJ
binding/NN
complex/NN
formation/NN
with/IN
the/DT
HIV-1/NN
promoter-enhancer/NN
associated/VBN
with/IN
markedly/RB
less/JJR
viral/JJ
RNA/NN
production/NN
./.
=====
This/DT
absence/NN
of/IN
binding/NN
was/VBD
localized/JJ
to/TO
the/DT
NF-kappa/NN
B/NN
region/NN
of/IN
the/DT
HIV-1/NN
enhancer/NN
;/:
the/DT
65-kDa/JJ
plus/CC
50-kDa/JJ
NF-kappa/NN
B/NN
heterodimer/NN
was/VBD
preferentially/RB
lost/VBN
./.
=====
Adding/VBG
purified/VBN
NF-kappa/NN
B/NN
protein/NN
to/TO
nuclear/JJ
extracts/NNS
from/IN
cells/NNS
with/IN
restricted/JJ
expression/NN
overcomes/VBZ
this/DT
lack/NN
of/IN
binding/NN
./.
=====
In/IN
addition/NN
,/,
treatment/NN
of/IN
these/DT
nuclear/JJ
extracts/NNS
with/IN
sodium/NN
deoxycholate/NN
restored/VBD
their/PRP$
ability/NN
to/TO
form/VB
the/DT
heterodimer/NN
,/,
suggesting/VBG
the/DT
presence/NN
of/IN
an/DT
inhibitor/NN
of/IN
NF-kappa/NN
B/NN
activity/NN
./.
=====
Furthermore/RB
,/,
treatment/NN
of/IN
nuclear/JJ
extracts/NNS
from/IN
these/DT
cells/NNS
that/WDT
had/VBD
restricted/JJ
expression/NN
with/IN
lipopolysaccharide/NN
increased/VBD
viral/JJ
production/NN
and/CC
NF-kappa/NN
B/NN
activity/NN
./.
=====
Antiserum/NN
specific/JJ
for/IN
NF-kappa/NN
B/NN
binding/NN
proteins/NNS
,/,
but/CC
not/RB
c-rel-specific/JJ
antiserum/NN
,/,
disrupted/VBD
heterodimer/NN
complex/NN
formation/NN
./.
=====
Thus/RB
,/,
both/DT
NF-kappa/NN
B-binding/JJ
complexes/NNS
are/VBP
needed/VBN
for/IN
optimal/JJ
viral/JJ
transcription/NN
./.
=====
Binding/NN
of/IN
the/DT
65-kDa/JJ
plus/CC
50-kDa/JJ
heterodimer/NN
to/TO
the/DT
HIV-1/NN
enhancer/NN
can/MD
be/VB
negatively/RB
regulated/VBN
in/IN
monocytes/NNS
,/,
providing/VBG
one/CD
mechanism/NN
restricting/VBG
HIV-1/NN
gene/NN
expression/NN
./.